RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Health Sciences Stock

Health Sciences Revenue 2024

Health Sciences Revenue

34.28 M USD

Ticker

IWKS

ISIN

US0010582056

In 2024, Health Sciences's sales reached 34.28 M USD, a 19.36% difference from the 28.72 M USD sales recorded in the previous year.

The Health Sciences Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
200834.2842,28
200728.7237,80
20062537,31
200523.1438,67
200419.8338,60
200318.0434,24
200220.0933,90
200124.0531,56
200025.3730,59
199929.3730,34
199833.7731,21
199737.0532,66
199636.5333,12
199526.5934,45
199430.5130,97
199338.2631,05
199238.2628,93
199138.0326,30
199048.2931,81
198945.4532,67

Health Sciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Health Sciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Health Sciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Health Sciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Health Sciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Health Sciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Health Sciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Health Sciences’s growth potential.

Health Sciences Revenue, EBIT and net profit per share

DateHealth Sciences RevenueHealth Sciences EBITHealth Sciences Net Income
200834.28 M undefined-4.41 M undefined-11.05 M undefined
200728.72 M undefined-933,000 undefined-4.67 M undefined
200625 M undefined1.04 M undefined1 M undefined
200523.14 M undefined1.35 M undefined1.9 M undefined
200419.83 M undefined1.45 M undefined1.35 M undefined
200318.04 M undefined0 undefined-1.52 M undefined
200220.09 M undefined390,000 undefined90,000 undefined
200124.05 M undefined-380,000 undefined-1.74 M undefined
200025.37 M undefined-430,000 undefined-810,000 undefined
199929.37 M undefined-930,000 undefined-2.21 M undefined
199833.77 M undefined520,000 undefined-3.33 M undefined
199737.05 M undefined2.13 M undefined1.55 M undefined
199636.53 M undefined1.54 M undefined700,000 undefined
199526.59 M undefined1.52 M undefined920,000 undefined
199430.51 M undefined180,000 undefined-4.18 M undefined
199338.26 M undefined1.57 M undefined-1.26 M undefined
199238.26 M undefined970,000 undefined-530,000 undefined
199138.03 M undefined10,000 undefined-1.19 M undefined
199048.29 M undefined2.75 M undefined420,000 undefined
198945.45 M undefined2.31 M undefined-190,000 undefined

Health Sciences stock margins

The Health Sciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Health Sciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Health Sciences.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Health Sciences's sales revenue. A higher gross margin percentage indicates that the Health Sciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Health Sciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Health Sciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Health Sciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Health Sciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Health Sciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Health Sciences Margin History

Health Sciences Gross marginHealth Sciences Profit marginHealth Sciences EBIT marginHealth Sciences Profit margin
200842.28 %-12.86 %-32.23 %
200737.8 %-3.25 %-16.27 %
200637.31 %4.14 %4.02 %
200538.67 %5.85 %8.21 %
200438.6 %7.33 %6.79 %
200334.24 %0 %-8.4 %
200233.9 %1.94 %0.45 %
200131.56 %-1.58 %-7.23 %
200030.59 %-1.69 %-3.19 %
199930.34 %-3.17 %-7.52 %
199831.21 %1.54 %-9.86 %
199732.66 %5.75 %4.18 %
199633.12 %4.22 %1.92 %
199534.45 %5.72 %3.46 %
199430.97 %0.59 %-13.7 %
199331.05 %4.1 %-3.29 %
199228.93 %2.54 %-1.39 %
199126.3 %0.03 %-3.13 %
199031.81 %5.69 %0.87 %
198932.67 %5.08 %-0.42 %

Health Sciences Aktienanalyse

What does Health Sciences do?

The Health Sciences Corp is a company that has been active in the biotechnology industry since 1997. It was founded with the goal of developing practical and innovative solutions for medical problems. The company is based in Toronto, Canada, and operates worldwide. The business model of the Health Sciences Corp includes several divisions, all focused on the field of biotechnology. The main divisions are the development of diagnostic tests, drug development, and the production of medical devices. In the field of diagnostic tests, the Health Sciences Corp offers various products that are intended to contribute to faster and more accurate disease diagnosis. An example of this is the reliable blood glucose test, which is particularly used in the diagnosis of diabetes and other metabolic diseases. The company also offers tests for the detection of infectious diseases such as HIV or hepatitis. In the area of drug development, the Health Sciences Corp focuses on developing innovative solutions for particularly difficult-to-treat diseases. These include cancer, autoimmune, and neurodegenerative diseases. Both completely new active substances and novel combinations of existing therapies are developed for this purpose. In addition to drug development, the company also works on the production of medical products. This includes implants as well as devices for monitoring vital parameters. An example of this is the wireless sensor for monitoring heart rhythm disorders, which is applied to the patient's skin and transfers data to the doctor's mobile phone. Over the years, the Health Sciences Corp has received numerous awards and prizes for technological innovations as well as medical research. The company makes a particularly significant contribution to cancer research. It works closely with renowned research institutions and universities, thus constantly contributing to new findings. The knowledge gained in the process also flows into the development of new therapies. In 2016, the Health Sciences Corp founded a subsidiary called MaRS Innovation, which aims to commercialize technology from Canadian universities. The goal is to transform new technologies that have been researched in universities into commercial products and services. The vision of the Health Sciences Corp is to contribute to sustainably improving healthcare for people worldwide through innovative therapies and medications. In addition, the company places great importance on adhering to ethical and moral standards and behaving respectfully towards the environment and society. Overall, the company has an excellent reputation in the biotechnology industry and is considered a pioneer in the development of practical and innovative solutions for medical problems. Health Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Health Sciences's Sales Figures

The sales figures of Health Sciences originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Health Sciences’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Health Sciences's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Health Sciences’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Health Sciences stock

How much revenue did Health Sciences generate this year?

Health Sciences has achieved a revenue of 34.28 M USD this year.

How much was the turnover of the company Health Sciences compared to the previous year?

The revenue of Health Sciences has increased by 19.36% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Health Sciences?

The revenue of Health Sciences is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Health Sciences measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Health Sciences so important for investors?

The revenue of Health Sciences is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Health Sciences pay?

Over the past 12 months, Health Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Health Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Health Sciences?

The current dividend yield of Health Sciences is .

When does Health Sciences pay dividends?

Health Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Health Sciences?

Health Sciences paid dividends every year for the past 0 years.

What is the dividend of Health Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Health Sciences located?

Health Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Health Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Health Sciences from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Health Sciences pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Health Sciences in the year 2023?

In the year 2023, Health Sciences distributed 0 USD as dividends.

In which currency does Health Sciences pay out the dividend?

The dividends of Health Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Health Sciences

Our stock analysis for Health Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Health Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.